HK1249182A1 - 验证生物标志物测量 - Google Patents

验证生物标志物测量 Download PDF

Info

Publication number
HK1249182A1
HK1249182A1 HK18108825.4A HK18108825A HK1249182A1 HK 1249182 A1 HK1249182 A1 HK 1249182A1 HK 18108825 A HK18108825 A HK 18108825A HK 1249182 A1 HK1249182 A1 HK 1249182A1
Authority
HK
Hong Kong
Prior art keywords
biomarker
value
determining
validating
biomarkers
Prior art date
Application number
HK18108825.4A
Other languages
English (en)
Chinese (zh)
Inventor
Leo Charles Mchugh
Original Assignee
Immunexpress Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015901982A external-priority patent/AU2015901982A0/en
Application filed by Immunexpress Pty Ltd filed Critical Immunexpress Pty Ltd
Publication of HK1249182A1 publication Critical patent/HK1249182A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Software Systems (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Public Health (AREA)
  • Bioethics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK18108825.4A 2015-05-28 2016-05-20 验证生物标志物测量 HK1249182A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015901982 2015-05-28
AU2015901982A AU2015901982A0 (en) 2015-05-28 Validating biomarker measurement
PCT/AU2016/050388 WO2016187655A1 (en) 2015-05-28 2016-05-20 Validating biomarker measurement

Publications (1)

Publication Number Publication Date
HK1249182A1 true HK1249182A1 (zh) 2018-10-26

Family

ID=57392259

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108825.4A HK1249182A1 (zh) 2015-05-28 2016-05-20 验证生物标志物测量

Country Status (9)

Country Link
US (2) US20180107783A1 (cg-RX-API-DMAC7.html)
EP (1) EP3304093B1 (cg-RX-API-DMAC7.html)
JP (1) JP2018525703A (cg-RX-API-DMAC7.html)
CN (1) CN108323184A (cg-RX-API-DMAC7.html)
AU (1) AU2016267392B2 (cg-RX-API-DMAC7.html)
CA (1) CA2986787A1 (cg-RX-API-DMAC7.html)
DK (1) DK3304093T3 (cg-RX-API-DMAC7.html)
HK (1) HK1249182A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016187655A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180107783A1 (en) * 2015-05-28 2018-04-19 Immunexpress Pty Ltd Validating biomarker measurement
CA3002196C (en) * 2015-10-30 2024-05-14 Exact Sciences Development Company, Llc Multiplex amplification detection assay and isolation and detection of dna from plasma
CN111033631B (zh) * 2017-06-13 2024-03-12 波士顿基因公司 用于生成分子功能谱、对其进行可视化和分类的系统和方法
AU2018312117B2 (en) * 2017-08-04 2022-05-12 Billiontoone, Inc. Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets
AU2018324195B2 (en) 2017-09-01 2024-12-12 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
WO2019183052A1 (en) * 2018-03-19 2019-09-26 Sri International Methods and systems for biomarker analysis
CN109055535A (zh) * 2018-09-14 2018-12-21 北京泱深生物信息技术有限公司 血液中的分子作为诊断脓毒症的标志物
CN109374904A (zh) * 2018-10-29 2019-02-22 浙江医院 一种蛋白质类脓毒症标志物及其在严重脓毒症早期预警的应用及其筛选方法
JP2022553570A (ja) * 2019-11-05 2022-12-23 アピール テクノロジー,インコーポレイテッド 植物生産物における感染の予測
US11049590B1 (en) 2020-02-12 2021-06-29 Peptilogics, Inc. Artificial intelligence engine architecture for generating candidate drugs
WO2021202620A1 (en) * 2020-03-31 2021-10-07 The Board Of Trustees Of The Leland Stanford Junior University Metabolomics approach combined with machine learning to recognize a medical condition
CN113488107B (zh) * 2021-07-07 2022-07-19 广州华银康医疗集团股份有限公司 筛选免疫组库测序生物标志物的方法、设备和存储介质
EP4195212A1 (en) * 2021-12-08 2023-06-14 A3P Biomedical AB (publ) Certainty-based medical conclusion model adaptation
CN114628024A (zh) * 2022-02-24 2022-06-14 重庆市急救医疗中心(重庆市第四人民医院、重庆市急救医学研究所) 一种生物标志物组在制备用于辅助筛查脓毒症的产品中的用途和辅助筛查方法及其系统
WO2025094604A1 (ja) * 2023-10-31 2025-05-08 アークレイ株式会社 検知方法、検知装置、検知システム、検知プログラム、及び記録媒体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148339A1 (en) 2001-05-07 2003-08-07 Hrissi Samartzidou Artificial genes for use as controls in gene expression analysis systems
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US20040180365A1 (en) 2002-12-13 2004-09-16 Affymetrix, Inc. Methods and computer software products for gene expression data quality analysis
WO2006023769A2 (en) 2004-08-18 2006-03-02 Abbott Molecular, Inc. Determining data quality and/or segmental aneusomy using a computer system
JP2008538007A (ja) * 2005-04-15 2008-10-02 ベクトン,ディッキンソン アンド カンパニー 敗血症の診断
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US20070255113A1 (en) * 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20080213768A1 (en) * 2006-08-17 2008-09-04 Zhauhui Cai Identification and use of biomarkers for non-invasive and early detection of liver injury
DE102007010252B4 (de) 2007-03-02 2013-07-04 Sirs-Lab Gmbh Kontrollgene zur Normalisierung von Genexpressionsanalysedaten
CA2604317C (en) * 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
JP4666237B2 (ja) 2008-07-09 2011-04-06 ソニー株式会社 遺伝子検定方法、遺伝子検定プログラム及び遺伝子検定装置
EP2494364A1 (en) * 2009-10-29 2012-09-05 Tethys Bioscience, Inc. Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
WO2011139901A1 (en) 2010-04-29 2011-11-10 Esoterix Genetic Laboratories, Llc Gc wave correction for array-based comparative genomic hybridization
AU2011334548B2 (en) * 2010-11-26 2016-06-09 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
JP2014507160A (ja) * 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス.アー.エール.エル. 循環バイオマーカー
JP6211511B2 (ja) * 2011-04-18 2017-10-11 ディアミール, エルエルシーDiamir, Llc miRNAに基づくユニバーサルスクリーニングテスト(UST)
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
EP3255435A1 (en) * 2012-04-13 2017-12-13 Oasis Diagnostics Corporation Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases
CN105518153A (zh) 2013-06-20 2016-04-20 因姆内克斯普雷斯私人有限公司 生物标志物鉴定
WO2015117204A1 (en) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
US20180107783A1 (en) * 2015-05-28 2018-04-19 Immunexpress Pty Ltd Validating biomarker measurement

Also Published As

Publication number Publication date
US10719579B2 (en) 2020-07-21
DK3304093T3 (da) 2024-02-12
EP3304093A1 (en) 2018-04-11
JP2018525703A (ja) 2018-09-06
CA2986787A1 (en) 2016-12-01
EP3304093B1 (en) 2023-12-27
CN108323184A (zh) 2018-07-24
WO2016187655A1 (en) 2016-12-01
US20160350477A1 (en) 2016-12-01
AU2016267392A1 (en) 2017-12-07
EP3304093A4 (en) 2019-02-06
AU2016267392B2 (en) 2021-12-09
US20180107783A1 (en) 2018-04-19

Similar Documents

Publication Publication Date Title
MX373248B (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
WO2019048927A3 (en) METHODS AND DEVICES FOR DETECTION OF BIOMARKERS ASSOCIATED WITH PRECLAMPSIA
IL287810A (en) Kits for detecting one or more target nucleic acid analytes in a sample and methods of making and using the same
EP4674976A3 (en) Methods for detecting target nucleic acids in a sample
NZ629555A (en) Monocyte biomarkers for cancer detection
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
WO2015159293A3 (en) A method and kit for determining the tissue or cell origin of dna
PL3811061T3 (pl) Sposób wykrywania do wykrywania analitu w próbce
WO2014140974A3 (en) System and method for determining risk of diabetes based on biochemical marker analysis
EP4361609A3 (en) Signal encoding and decoding in multiplexed biochemical assays
BR112015009901A2 (pt) elementos de ensaio , material reagente e método para a determinação dos primeiro e segundo analitos em uma amostra.
WO2015126935A3 (en) Automated profiling of the hardness of wood
MX389578B (es) Analizador de fluidos para la medición de iones de magnesio y método de calibración del sensor potenciométrico de iones de magnesio en el mismo
GB2549017A (en) Determining the oleophilic to aqueous phase fluid ratio for drilling fluids
WO2013112836A3 (en) Diagnostic and prognostic biomarkers for cancer
EP3304093A4 (en) VALIDATION OF BIOMARK MEASUREMENT
DK3742153T3 (da) Fremgangsmåde til kvantificering af det samlede indhold af saponiner i en prøve, navnlig i en kompleks prøve
HK1232290A1 (zh) 检测人类骨膜蛋白的新型测定
MX2020002787A (es) Metodo para el analisis de metilacion.
GB2554282A (en) Lock mass library for internal correction
GB2552271A (en) A method for diagnosing lung cancer
MX2019003931A (es) Metodo y sistema de analisis para analizar una muestra.
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
WO2015197915A3 (en) Biochemical markers for use in determining risk of diabetes